Neurofibromatosis type 1: New insights into neurocognitive issues
Authors:
- Maria T. AcostaMAMaria T. Acosta
- Gerard A. GioiaGGGerard A. Gioia
- Alcino J. SilvaASAlcino J. Silva
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 6 (2) , 136-143
Abstract
Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder with a prevalence of approximately 1 in 3500 people. Academic difficulties and school failure are the most common reported complication of NF1 in childhood and are present in 40% to 60% of the cases. They are often the most significant cause of lifetime morbidity in this population. Recent advances in the recognition and characterization of the cognitive phenotype in NF1 patients have provided a better understanding of the neuropsychologic deficits that account for the impairments in cognitive performance and social interaction. Additionally, recent advances in the understanding of molecular and cellular mechanisms underlying the cognitive deficits in NF1, as well as developments in neuroimaging and molecular genetic techniques are starting to yield a global and integrative picture of the molecular, cellular, and brain system processes affected by this condition. This review focuses on these advances, as well as recent preclinical studies that point towards potential pharmacologic interventions for NF1 patients.Keywords
This publication has 55 references indexed in Scilit:
- Perspectives on farnesyl transferase inhibitors in cancer therapyCancer Letters, 2004
- Molecular Genetics of Human CognitionMolecular Interventions, 2002
- Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1Journal of Child Neurology, 2002
- Profiles of Everyday Executive Function in Acquired and Developmental DisordersChild Neuropsychology, 2002
- The Association of Neurofibromatosis Type 1 and Attention Deficit Hyperactivity DisorderChild Neuropsychology, 2000
- How Children With Neurofibromatosis Type 1 Differ From "Typical" Learning Disabled Clinic Attenders: Nonverbal Learning Disabilities RevisitedDevelopmental Neuropsychology, 2000
- NEUROPSYCHOLOGICAL FUNCTION AND MRI ABNORMALITIES IN NEUROFIBROMATOSIS TYPE 1Developmental Medicine & Child Neurology, 1995
- Neurofibromatosis type 1: The cognitive phenotypeThe Journal of Pediatrics, 1994
- Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segmentsHuman Molecular Genetics, 1993
- The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytesNeuron, 1992